Harmine
| Harmine | |
|---|---|
| Salts [] | |
|---|---|
| Harmine hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 212.25 g/mol [1] |
| Melting point | 264 - 265 °C [1] |
| Predicted LogP | 3.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C13H12N2O |
| IUPAC name | 7-methoxy-1-methyl-9H-pyrido[3,4-b]indole |
| SMILES | CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC |
| InChI | InChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3 |
| InChIKey | BXNJHAXVSOCGBA-UHFFFAOYSA-N |
| CAS number | 442-51-3 |
| UNII | 4FHH5G48T7 |
| PubChem CID | 5280953 |
| Pharmacokinetics[] | |
|---|---|
| Onset | Unknown |
| Elimination half-life | 1.3–1.9 hours (1–3 hours)[3] |
| Duration of action | Oral: 6–8 hours, Intramuscular injection: 3–5 hours, Intravenous injection: 30–45 minutes[4][5][6] |
| Routes of administration | Oral, sublingual, subcutaneous injection, intramuscular injection, intravenous injection |
Harmine (also known as Banisterine, Telepathine, Leucoharmine, Yageine, Yajeine, 9H-Pyrido[3,4-b]indole, 7-methoxy-1-methyl-, 1-Methyl-7-methoxy-β-carboline, 7-Methoxy-1-methyl-9H-pyrido(3,4-b)indole, 9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl- or 207-131-4) is a monoamine oxidase inhibitor substance of the β-carboline class.
It is a constituent of tobacco.
Chemistry
Salts []
Harmine is typically found in the form of its hydrochloride salt.
Stereochemistry []
Harmine is achiral.
Druglikeness
Lipinski's rule of five
Harmine matches Lipinski's rule of five.Reagents
There are currently 6 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | yellow > red | |
| Mecke | yellow > green | |
| Mandelin | black | |
| Simon's | no blue color change | |
| Ehrlich | no color change | |
| Hofmann | no color change |
Pharmacology
MeSH Classification
Experience reports
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5280953, Harmine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5280953
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Harmine. UNII: 4FHH5G48T7. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4FHH5G48T7
Brito-da-Costa AM, Dias-da-Silva D, Gomes NG, Dinis-Oliveira RJ, Madureira-Carvalho Á. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact. Pharmaceuticals (Basel). October 2020; 13(11):334. PMID 33114119.
Dos Santos RG, Hallak JE. Ayahuasca: pharmacology, safety, and therapeutic effects. CNS Spectr. November 2024; 30(1). PMID 39564645.
Mueller MJ, Aicher HD, Dornbierer DA, Marten L, Suay D, Meling D, Elsner C, Wicki IA, Müller J, Poetzsch SN, Caflisch L, Hempe A, Steinhart CP, Puchkov M, Kost J, Landolt HP, Seifritz E, Quednow BB, Scheidegger M. Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial. Int J Neuropsychopharmacol. December 2024; 28(1). PMID 39774840.
Egger K, Jareño Redondo J, Müller J, Dornbierer J, Smallridge J, Aicher HD, Meling D, Müller P, Kost J, Puchkov M, Äbelö A, Seifritz E, Quednow BB, von Rotz R, Scheidegger M, Dornbierer DA. Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study. Biomed Pharmacother. March 2025; 184(). PMID 39923404.
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 11:54:57 |
| drugspro | ok | 2026-11-20 11:54:53 |
| erowid | ok | 2026-11-20 11:54:58 |
| gsrs | ok | 2026-11-20 11:54:54 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0030311) | 2026-11-20 11:54:53 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 11:54:57 |
| pubchem | ok | 2026-11-20 11:54:53 |
| ok | 2026-11-20 11:54:53 | |
| sider | missing (not in SIDER) | 2026-11-20 11:54:53 |
| structure | ok | 2026-11-20 11:54:53 |
| wikipedia | ok | 2026-11-20 11:54:54 |